ESC Premium Access

Advances in Treatment of Acute Coronary Syndrome

Event: ESC CONGRESS 2020 - The Digital Experience
Topic: Treatment
Session type: Rapid Fire Abstracts
Date: 1 September 2020
Time: 08:30 - 08:30

Session

6 presentations in this session

Low-density lipoprotein cholesterol <50 mg/dL is an appropriate target after acute coronary syndrome: propensity score-matched analysis of the ODYSSEY OUTCOMES trial

Speaker: Professor G. Schwartz (Aurora, US)
Thumbnail

Onyx ONE: Outcomes in patients with acute coronary syndrome

Speaker: Doctor E. Kedhi (Brugge, BE)
Thumbnail

Differences in revascularization strategy and outcomes in ST-elevation and non-ST-elevation myocardial infarction with spontaneous coronary artery dissection

Speaker: Doctor T. Inohara (Tokyo, JP)
Thumbnail

Prasugrel compared to ticagrelor in primary PCI

Speaker: Doctor J. Doerler (Innsbruck, AT)
Thumbnail

Low dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndrome (LILACS)

Speaker: Doctor T. Zhao (Cambridge, GB)
Thumbnail

Sex disparities in completeness of revascularisation and outcomes in patients with ST-elevation myocardial infarction and multivessel coronary artery disease.

Speaker: Doctor N. Mahdi (Calgary, CA)
Thumbnail

6 speakers from this session

Professor Gregory Schwartz

University of Colorado School of Medicine, Aurora (United States of America)
2 presentations
0 follower

Doctor Elvin Kedhi

St-Jan Hospital, Brugge (Belgium)
0 follower

Doctor Taku Inohara

Keio University School of Medicine, Tokyo (Japan)
0 follower

Doctor Jakob Doerler

Innsbruck Medical University, Department of Internal Medicine III, Cardiology, Innsbruck (Austria)
0 follower

Doctor Tian Zhao

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Nabila Mahdi

Libin Cardiovascular Institute Of Alberta, Calgary (Canada)
0 follower

This platform is supported by

logo Novo Nordisk